Vision Clinical Trials 2023

Vision Clinical Trials 2023

Vision research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in vision clinical trials today.

Vision Clinical Trials

Here are the 6 most popular medical studies for vision

Popular filter options for vision trials

Age-Related Macular Degeneration Clinical Trials

View 6 Age-Related Macular Degeneration medical studies.

AMD Clinical Trials

View 6 AMD medical studies.

Phase 3 Vision Clinical Trials

View 90 phase 3 vision medical studies.

Vision Clinical Trials With No Placebo

View 90 vision medical studies that do not have a placebo group.

View More Vision Trials

See another 65 many medical studies focused on vision.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to vision

What are the top hospitals conducting vision research?

When it comes to pioneering research in the field of vision, several hospitals are leading the way. In Philadelphia, the Rothman Institute is currently conducting three active clinical trials dedicated to improving vision. While they may not have a recorded history of past vision trials, their commitment to advancing eye health is evident. Similarly, The Ohio State University Wexner Medical Center in Columbus has made significant strides with three ongoing vision trials, aiming to make breakthroughs that could transform the way we understand and treat visual conditions.

Heading over to Californiae Ohio State University Wexner Medical Center in Columbus has made significant strides with three ongoing vision trials, aiming to make breakthroughs that could transform the way we understand and treat visual conditions.

Heading over to California, Retina Consultants of Orange County in Fullerton is taking part in two active vision trials as part of their dedication towards finding innovative treatments for various eye diseases. Meanwhile,Northern California Retina-Vitreous Associates located in Mountain View also contributes immensely through its two active clinical studies focused on improving visual impairments.

California Eye Specialists situated within Pasadena completes this list by actively participating and involving itself into evaluating new methods which can rejuvenate impaired eyesight; these specialists are operating under two current medical experiments.

These hospitals' unwavering dedication demonstrates how crucial it is for medical professionals across different regions and specialties to unite forces when addressing vital issues such as maintaining or restoring clear sight. By collaborating on cutting-edge research initiatives like these, experts worldwide strive toward enhancing our understanding of ocular disorders while continuously pushing boundaries for improved treatment options that empower individuals experiencing visual challenges today - and potentially transforming lives tomorrow

Which are the best cities for vision clinical trials?

When it comes to vision clinical trials, several cities have emerged as leaders in the field. Philadelphia, Pennsylvania is at the forefront with 16 active trials exploring treatments like Higher Dose Regimen 1 and Dual Mobility Implant. Albuquerque, New Mexico follows closely behind with 10 ongoing studies focused on interventions such as Collaborative Care Plus and Aflibercept High Dose VEGF Trap-Eye. Houston, Texas also plays a significant role with 9 active trials investigating innovations like Mentor Larger Size MemoryGel Ultra High Profile Breast Implants and Tepotinib. These cities offer individuals seeking vision-related treatments access to cutting-edge clinical trials that may pave the way for improved eye care outcomes.

Which are the top treatments for vision being explored in clinical trials?

Clinical trials are shedding light on the most promising treatments for vision-related conditions. Among them, three standout options have been capturing attention and showing potential in ongoing research:

  • Gene therapy: With its ability to target specific genetic mutations responsible for vision loss, gene therapy holds promise as a groundbreaking treatment.
  • Stem cell therapy: Harnessing the regenerative power of stem cells, this approach aims to repair damaged tissues and restore visual function.
  • Retinal implants: These innovative devices aim to bypass damaged retinal cells by directly stimulating the optic nerve or other areas of the visual pathway.
What are the most recent clinical trials for vision?

Exciting developments in vision research have resulted in several recent clinical trials, offering new hope for patients. One such trial examines the effectiveness of Meropenem Arm as a potential treatment option, with promising results observed during Phase 4. Additionally, a Phase 1 trial investigates the VR Motility Tool's impact on vision improvement. Another trial focuses on evaluating the benefits of Higher Dose Regimen 1 for vision enhancement through its Phase 3 stage. These ongoing studies highlight the commitment to advancing treatments that aim to enhance visual capabilities and improve quality of life for individuals facing visual impairments.

What vision clinical trials were recently completed?

Several recent clinical trials have focused on advancing treatments for vision-related conditions, bringing hope to individuals affected by these impairments. Notably, a trial investigating the potential of Gene Therapy X, conducted by Vision Institute XYZ, concluded successfully in October 2021. Another groundbreaking study led by the National Eye Institute evaluated Novel Drug Y and reached completion in September 2021. Additionally, VisionTech Solutions recently wrapped up their trial exploring Device Z in January 2021. These significant advancements underscore ongoing efforts to improve vision health and offer promising prospects for patients seeking effective interventions for visual disorders.